Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ainos (AIMD) Research & Development (2019 - 2025)

Ainos (AIMD) has disclosed Research & Development for 12 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 1.56% year-over-year to $2.0 million, compared with a TTM value of $8.0 million through Sep 2025, down 4.42%, and an annual FY2024 reading of $8.4 million, up 14.99% over the prior year.
  • Research & Development was $2.0 million for Q3 2025 at Ainos, up from $1.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.3 million in Q4 2024 and bottomed at $646798.0 in Q3 2021.
  • Average Research & Development over 5 years is $1.8 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Research & Development skyrocketed 183.67% in 2022, then decreased 17.3% in 2025.
  • Year by year, Research & Development stood at $1.3 million in 2021, then soared by 41.22% to $1.8 million in 2022, then grew by 24.36% to $2.2 million in 2023, then rose by 4.08% to $2.3 million in 2024, then decreased by 14.5% to $2.0 million in 2025.
  • Business Quant data shows Research & Development for AIMD at $2.0 million in Q3 2025, $1.9 million in Q2 2025, and $1.7 million in Q1 2025.